Abstract Both soy isoflavone and n-3 polyunsaturated fatty acids are known to reduce the levels of bone-resorbing cytokines; however, the synergistic effects of these food ingredients have not been examined yet. This study was performed to elucidate the effect of concomitant intake of soy isoflavone and fish oil on bone mass in ovariectomized mice. Eight-week-old ddY female mice were subjected to ovariectomy (OVX) or sham surgery, and then fed an AIN-93G with safflower oil (So) as a control lipid source, isoflavone-supplemented safflower oil (So ? I), fish oil instead of safflower oil (Fo) or isoflavone-supplemented fish oil (Fo ? I) for 4 weeks. Femoral bone mineral density was significantly decreased by OVX; however, this decrease was inhibited by the intake of isoflavone and/or fish oil. Histomorphometric analyses showed that bone volume and trabecular thickness in the distal femoral trabecular bone were significantly lower in the So group than in the sham group, but those were restored in the Fo ? I groups. The number of osteoclasts was significantly decreased by isoflavone intake.
Introduction
The incidence of hip fracture caused by osteoporosis in Asians is lower than that in Europeans and Americans, despite the fact that the prevalence of vertebral fracture is higher in Asian populations [1] [2] [3] .
Epidemiological studies indicate that women who have a high soy intake have a lower risk of osteoporosis than women who consume a typical Western diet [4] [5] [6] . Consequently, many menopausal women use phytoestrogens to maintain their bone mineral density (BMD) because they are unlikely to cause the undesirable effects associated with steroid hormones [7, 8] . A meta-analysis of randomized controlled trials (RCTs) has estimated the effect of ingesting soy isoflavones on lumbar spine BMD [9] . However, soy isoflavone or protein intervention trials in postmenopausal women indicated modest or no effects of soy isoflavones on preserving BMD in the hip or spine [10] [11] [12] [13] [14] [15] . Thus, the efficacy of soy isoflavones on preventing bone loss seems to be still contradictory. One of solutions might be effective daily intake of isoflavones and consuming periods. Ma et al. [9] suggested that the favorable effect became more significant when [90 mg/ day of isoflavones were consumed, and soy isoflavone consumption for 6 months could be enough to exert beneficial effects on bone in menopausal women.
Asian diets also include large amounts of fishes such as sardines and tuna. These fishes contain oil that is abundant in n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have well-known anti-inflammatory and immunomodulatory effects [16, 17] . Fish oil increases the ratio of n-3/n-6 fatty acids and competitively inhibits prostaglandin E 2 (PGE 2 ) production from arachidonic acid, which is a metabolite of the n-6 PUFA, linoleic acid [18] . PGE 2 enhances production of the bone-resorbing cytokines, including IL-1, IL-6 and TNF-a, and promotes bone resorption by induction of the differentiation of osteoprecursors to osteoclasts [19] . Intake of oil with a high content of n-3 PUFAs also decreases the amount of PGE 2 in bones [20] , and Sun et al. [21] demonstrated that fish oil had a greater effect than corn oil in inhibiting bone loss after ovariectomy. These studies suggest that n-3 PUFAs regulate the production of bone-resorbing cytokines and thereby maintain bone mass.
Nutritional factors are important in the primary prevention of osteoporosis, and intake of either soy isoflavone or fish oil alone has been shown to inhibit bone loss. Ward et al. [22] reported that the combination intakes of genistein, daidzein and polyunsaturated fatty acid (PUFA) showed an additive effect in preventing bone loss at the lumbar spine. Another report [23] indicated a complementary action of the dietary combination of soy isoflavone and 25% n-3 PUFA for attenuating bone mineral reduction in OVX rats at the tibia. However, these reports did not clarify the inhibitory effect of combination intakes of isoflavone glycoside and a low dose of n-3 PUFA on bone loss in OVX animals. Therefore, the current study was performed in order to assess the inhibitory effect of soy isoflavone as glycoside and/or fish oil as PUFA on bone loss in ovariectomized mice, which have been used as a model of osteoporosis.
Materials and methods

Determination of isoflavone and fish oil contents in diets
Ohta et al. [24] and Hidaka et al. [25] have shown that isoflavone glycoside (Fujiflavone P-40) mixed with diets at concentrations of 0.5 and 0.25%, respectively, maintains the bone mass in ovariectomized mice with no effect on the uterus. Uesugi et al. [26] -1 ). On the basis of this conversion, the amount of the diet required was calculated to be 4 g per day per 40 g body weight, (Table 3) , and the diet was prepared containing 0.25% P-40 (genistein: 13 mg kg -1 day -1 ; daidzein: 56 mg kg -1 day -1 ). Then, we also examined whether the dose of a certain amount of fish oil taken for 4 weeks affected the BMD in intact female mice. Female C57BL/6J strain mice were obtained from Tokyo Laboratory Animals Science Co. (Tokyo, Japan) at 7 weeks of age and fed an AIN-93G diet for 1 week to stabilize the metabolic conditions. Mice were housed in a 12-h light/12-h dark cycle at a constant temperature of 22 ± 2°C and humidity of 55 ± 5%. The amount of fish oil increased from 0 to 50% lipid energy with a concomitant decrease of safflower oil from 50 to 0% lipid energy, maintaining the total amount of fat constant at 50% lipid energy. BMD of the femur was measured by dualenergy X-ray absorptiometry (DXA) by using a bone densitometer adapted for small animal research (model DCS-600R; Aloka, Tokyo, Japan). Whole femoral BMD was higher in the mice fed the diet containing 30 and 40% fish oil compared with that of 0% fish oil and 50% safflower oil groups. However, BMD tended to be higher (P = 0.07) in the group of mice fed the diet containing 20% fish oil than in that fed 0% fish oil (Fig. 1) . Based on these results, we decided that a submaximal dose of fish oil, 20%, was adopted for the dose for the combination study with isoflavone.
Therefore, this study was performed using 0.12% isoflavone P-40 and 8.0 w/w % fish oil (20% of lipid energy for total energy).
Experimental design
Eight-week-old female ddY strain mice were purchased from Japan SLC (Shizuoka, Japan). The mice were housed in individual cages in a temperature-and humiditycontrolled room, and were given free access to food and distilled water. The mice underwent either a sham-operation or were ovariectomized (OVX) (n = 7 for each group). Sham mice were fed a So diet, whereas OVX mice were divided into four groups that were fed a diet containing 8% safflower oil (So), So with 0.25% Fujiflavone P-40 (So ? I), 8% fish oil (Fo) or Fo with I (Fo ? I) for 4 weeks. Of the total fatty acid content of safflower oil, oleic acid (18:1n-9) and linoleic acid (18:2n-6) comprised approximately 45%, respectively. Similarly, the fish oil contained 7% EPA (20:5n-3) and 23% DHA (22:6n-3) ( Table 1) . Fujiflavone P-40 (isoflavone content, 46.6%; Fujicco, Kobe, Japan) was supplemented to the diets (0.25% in the diets). Fujiflavone P-40 contained daidzin (22.3%), glycitin (15.0%), genistin (5.4%), daidzein (0.2%), glycitein (0.4%), genistein (0.06%) and other isoflavones (3.2%). The dose of isoflavone conjugates in this study was approximately 0.12% in the So ? I and Fo ? I diets. The experimental diets were based on the AIN-93G diet with each oil as shown above replacing soybean oil [28] (Table 2) . At the end of the experiment, the mice were killed with pentobarbital sodium (Nembutal; Dainippon Pharmaceutical Co., Osaka, Japan). In each experiment, body and uterine weights were measured, and the right and left femora were removed for the measurement of BMD and histomorphometric analysis.
The study was approved by the Josai University Animal Use Committee, and the mice were maintained in accordance with the university guidelines for the care and use of laboratory animals.
Femoral BMD and bone structure index
The femoral BMD of mice was examined radiographically using computed tomography (CT) (LCT-100; LaTheta, ALOKA, Tokyo, Japan) according to the manufacturer's protocol. CT scanning was performed at 2-mm intervals from the diaphragm to the bottom of the abdominal cavity.
The minimum moment of inertia of cross-sectional areas and the polar moment of inertia of cross-sectional areas that represent the flexural rigidity and torsional rigidity, respectively, were also calculated automatically by the software attached to the device. According to the manufacturer, the precision error (as % CV) is within the 2% range for all measurements. Fig. 1 The effect of different dietary fish oil (Fo) contents (10-50% total lipid content) on femoral bone mineral density (BMD) in intact female C57BL/6J mice. Mice were fed the diet for 4 weeks. A diet containing safflower oil (So; 50% total lipid content) was used as a control. Data are the means ± SD for six mice. Means without a common letter are significantly different, P \ 0.05 (BV, mm 2 ), osteoid volume/bone volume (OV/BV, %), osteoid surface/ bone surface (OS/BS, %) and osteoid thickness (O.Th, lm).
Analysis of serum samples
Two serum bone metabolism markers, osteocalcin (OC) and the C-terminal telopeptide of type I collagen (CTx), were measured using a Mouse Osteocalcin EIA kit (Biomedical Technologies, Stoughton, MA) and a RatLaps ELISA kit (Nordic Bioscience Diagnostics A/S, Herlev, Denmark), respectively. Serum, TNF-a, IL-1 and PGE 2 were measured using Mouse TNF-a, IL-1 ELISA kits (Endogen, Rockford, IL) and a PGE 2 ELISA kit (Cayman, Ann Arbor, MI), respectively.
Time-resolved fluoroimmunoassay (TR-FIA) for serum genistein and daidzein
The TR-FIA technique has previously been used to measure serum genistein and daidzein [30] , and also serum equol [31] . After enzymatic hydrolysis and extraction by diethyl ether, serum genistein and daidzein concentrations were determined fluorometrically using a DELFIA Victor 1420 multilabel counter (Perkin Elmer, Wellesley, MA) and are expressed as nmol/l.
Statistical analysis
Results are expressed as the mean ± SD for each group. After one-way analysis of variance (ANOVA), Fisher's protected least significant difference (PLSD) test was used to determine significant differences among the groups. Differences were considered to be significant when the P value was less than 0.05.
Results
Body weight, food intake and uterine weight As shown in Table 3 , the body weight was increased by OVX, but food intake of the experimental animals did not differ among the five groups. Isoflavone intakes were also similar in both the groups administered isoflavone. The uterine weight was significantly decreased in OVX mice, and the intake of isoflavone and fish oil had no effect on uterine weight in these animals.
Femoral bone mineral density, bone metabolism markers, strength indexes and calcium contents
The whole, cortical and trabecular BMD was significantly lower in the So group than in the sham group (Table 4) . Administration of isoflavone and/or fish oil significantly inhibited the bone loss in the whole, cortical and trabecular bone, but the BMD in these groups that were fed the experimental diet did not recover to the sham level (Table 4) . Whole and cortical BMD was higher in the Fo ? I group than in the Fo group. Further, there was no significant difference in the cortical BMD between the sham and Fo ? I group. The mean values of minimum moment of inertia of cross-sectional areas and the polar moment of inertia of cross-sectional areas are shown in Table 5 . The former value represents the flexural rigidity, and the latter represents the torsional rigidity. These parameters were decreased by OVX, but the intake of isoflavone and/or fish oil significantly inhibited decreases. Serum CTx, a bone resorption marker, and OC, a bone formation marker, were increased in the So OVX group, and the increase was suppressed by the intake of isoflavone or fish oil, or the combined intake of these two ingredients (Table 6 ). The Ca content was significantly lower in the So OVX group than in the sham group, and administration of fish oil or the concomitant intake of isoflavone and fish oil inhibited the extent of this decrease (Table 5 ). High Ca levels were also observed in femora of mice that received isoflavone alone.
Bone histomorphometric analysis Figure 2 shows the histological analysis of trabecular bone collected from mice in each group. Many trabecular connectivities were observed in the cancellous bone area beneath the growth plate cartilage of the distal femur in sham mice, whereas most of connectivities in the lower region disappeared in OVX mice. The bone loss in the OVX ? Fo ? I group was markedly inhibited compared with the OVX ? So group; however, it was not restored to that in the sham group (Fig. 2a, b) .
In order to determine the effects of isoflavone administration on trabecular bone, histological sections of the distal femoral metaphysis were prepared, and BV/TV, and Tb.Th were evaluated (Fig. 2c) . BV/TV and Tb.Th were markedly decreased by OVX; however, the decrease of these parameters was significantly inhibited by the intake of isoflavone and/or fish oil. N.Oc/BS and BRs.R, the parameters of bone resorption, were significantly increased by OVX, but these were decreased by isoflavone intake, and and normalized by the combination of isoflavone and fish oil to the sham level. BFR/BV, the parameter of bone formation, was significantly increased by OVX, and the increase was inhibited by the intake of isoflavone and/or fish oil alone. Ob.S/BS (Fig. 2c) , BV, OV/BV, OS/BS and O.Th were significantly higher in So ? I group compared with the So group in OVX mice (Fig. 2d) . Table 4 Femoral BMD using qCT of sham mice fed the diet containing safflower oil (So) without soy isoflavone (I), OVX mice fed the diets containing So with or without I and OVX mice fed the diets of fish oil (Fo) with or without I for 4 weeks Values are means ± SD for seven mice; means in a column with different superscript letters differ, P \ 0.05 ) and mineral appositional rate (MAR, lm/day). d Bone volume (BV, mm 2 ), ratios of osteoid volume to bone volume (OV/BV, %) and osteoid surface to bone surface (OS/BS, %), and osteoid thickness (O.Th, lm). Microstructural parameters were determined as described in ''Materials and methods.'' Data are the mean ± SD of three mice. Means without a common letter are significantly different, P \ 0.05
Serum biochemical parameters
The serum TNF-a concentration was increased by OVX, and the increase was inhibited by the intake of isoflavone and/or fish oil. The serum IL-1 concentration was also increased by OVX, and the increase was normalized by the isoflavone intake. Further, the IL-1 concentration was lower in OVX mice fed the diets fish oil with isoflavone than in that in safflower oil with isoflavone or fish oil (Table 6) . A negative correlation was found between serum TNF-a concentrations and femoral BMD (Fig. 3) . The serum PGE 2 concentration was significantly higher in the So OVX group than in the sham group, and this was substantially reduced by the concomitant intake of isoflavone and fish oil (Table 6 ).
Serum isoflavone concentrations
By treatment with soy isoflavones, daidzein, genistein and equol were detected in serum. No significant differences were observed in the serum concentrations of these compounds between the So ? I and Fo ? I groups (daidzein, So ? I group: 330 ± 71; Fo ? I group: 280 ± 51; genistein, So ? I group: 122 ± 22; Fo ? I group: 102 ± 30 nmol/l serum). However, the serum equol level was 1.8-fold greater in the So ? I group than in the Fo ? I group (So ? I group: 1002 ± 56; Fo ? I group: 563 ± 77 nmol/l serum) ( Table 7) .
Discussion
Our results showed that isoflavone and fish oil at low doses have an additive effect on inhibiting bone loss, especially in the femoral trabecular bone, by inhibiting bone resorption in ovariectomized mice. In the current study, the BMD in the femur of mice was markedly decreased after ovariectomy. Intake of soy isoflavone and/or fish oil inhibited the decrease in femoral whole, cortical and trabecular BMD. The concomitant intake of isoflavone and fish oil had better effects in whole and cortical BMD than fish oil alone. Regarding trabecular BMD, the combination of fish oil and isoflavone showed a higher value than isoflavone alone. The changes in structural properties are associated with changes in both cross-sectional geometry and material properties [32] . The decreased minimum moment of inertia of cross-sectional areas and the polar moment of inertia of cross-sectional areas due to OVX were inhibited by the intake of soy isoflavone and/or fish oil. Furthermore, isoflavone and fish oil at concentrations that influenced BMD had no effect on uterine weight. It is suggested that the dose of isoflavone used in this study (approximately 120 mg/kg/day) does not have adverse effects. Ishida et al. [33] showed that administration of daidzin at 50 mg kg -1 day -1 or genistein at 100 mg kg
day -1 increased rat uterine weight, and Kanno et al. [34] found that administration of genistein at doses of 60 mg kg -1 day -1 or more induced uterine hypertrophy. Similarly, Ishimi et al. [35] showed that genistein aglycone induced uterine hypertrophy at a dose tenfold greater than that required to inhibit the decrease in bone mass (0.7 mg/day via skin).
The effect of n-3 PUFAs on bone metabolism has been investigated in numerous animal models including mice and rats [21, [36] [37] [38] [39] . The results of these studies suggested that fish oil and n-3 PUFA increased calcium absorption [40, 41] , increased bone formation [42, 43] , decreased calcium excretion [43] and decreased bone resorption [21, 39, 44] . However, as these studies have not reported any histomorphometric analyses, it is not known whether the observed differences in BMD were due to alternations in bone resorption and/or in bone formation. Bone mass is increased by endochondral and intramembranous ossification and by modeling and remodeling [45] . Our results showed that the concomitant intake of fish oil and isoflavone enhanced endochondral ossification (Fig. 2a) . We also observed various directions of osteoclast-induced bone resorption and maintenance of the trabecular thickness in mice with increased bone mass in the Fo ? I group. Reduced differentiation or activation of osteoclasts may decrease bone resorption. OVX mice with isoflavone intake in the current study showed a significant reduction in the increase of the number of osteoclast, suggesting inhibition of osteoclast differentiation. On the other hand, osteoid is formed by osteoblasts, and after a brief interval, this was mineralized also by the cells [46] [47] [48] . The results from BV, OV/BV, MAR and BFR/BV (Fig. 2c, d ) indicate that the intake of isoflavone alone increased osteoid volume, and that of fish oil alone increased MAR and BFR/BS, indicators of calcification. These results raised the possibility that the combination of soy isoflavone and fish oil promotes completeness of bone formation, that is, increased osteoid tissue (bone matrix) induced by the intake of isoflavone and enhanced mineralization of osteoid tissue induced by the intake of fish oil. The interactions of fish oil and isoflavone were observed in Tb.Th, Ob.S/BS and O.Th. (Fig. 2c, d ), suggesting that fish oil and isoflavone may increase bone mass synergistically in OVX mice. Intake of fish oil also reduces PGE 2 production [18, 43] , and PGE 2 enhances differentiation of osteoclast precursors and causes bone resorption [19] . Intake of fish oil was therefore expected to reduce osteoclast production. However, no reduction in the osteoclast surface was observed in mice with the intake of fish oil alone compared with the OVX ? So group. These results indicate that although fish oil reduces the bone resorption activity of osteoclasts, it does not influence osteoclast differentiation. Serum cytokine concentrations were also significantly reduced by the concomitant intake of isoflavones and fish oil compared to the intake of either component alone, and a negative correlation was found between TNF-a concentrations and femoral BMD. Therefore, the concomitant intake of soy isoflavone and fish oil appears to reduce the production of bone-resorbing cytokines in an additive manner and leads to reduced bone resorption. However, as described above, the mechanism by which soy isoflavone decreases the reduction in bone resorption may differ from that of fish oil. Consequently, additional studies are required in order to elucidate the regulatory mechanisms underlying osteoclast differentiation and bone-resorbing activity.
Equol is produced from daidzein in the gastrointestinal tract; however, interindividual variation exists in its metabolism in humans [49] . Fujioka et al. [50] reported that administration of equol inhibited bone loss induced by estrogen deficiency. In this study, despite the result indicating that there was no difference in isoflavone intakes in the So ? I and Fo ? I groups, the serum equol level in the Fo ? I group was lower than that in the So ? I group. These results raise the possibility of a complementary effect on bone metabolism induced by the intake of fish oil despite a decreased serum equol level in the Fo ? I group compared with that in the So ? I group. However, the mechanism by which the combined administration of isoflavone and fish oil decreases serum equol levels remains unclear.
The results of this study indicated that the intakes of soy isoflavone and/or fish oil may have ameliorating effects on bone loss because of OVX. Further, the concomitant intake of soy isoflavone and fish oil at a low dose showed better effects on cytokines related to bone resorption.
